French leader in plasma-derived medicinal products

With LFB BIOMEDICAMENTS, its subsidiary, the LFB Group is a major player in plasma-derived medicinal products. Ranking 3rd on the French hospital market, LFB Biomedicaments is the French leader in plasma-derived medicinal products. Our medicinal products are indicated in vital areas such as Immunology, Hemostasis, and Intensive Care, as part of the treatment of 80 serious and often rare pathologies.

Key figures:

• 19 medicinal products are marketed in France
• 1,500 care units order from us
• 500,000 patients are treated each year with LFB plasma-derived medicinal products
• 3.5 million plasma bags are fractionated each year